HUM-MOLGEN events: CHI's TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES

HUM-MOLGEN -> Events -> Meetings and Conferences

CHI's TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES

July 19, 2002

Cambridge Healthtech Institute, Washington Marriott, Washington, D.C.
February 12-13, 2003

Human blood, plasma and tissue contain many proteins, the extraction and purification of which are of great medical and economic importance. Transmission of infectious diseases via blood transfusion, tissue implantation and the use of processed blood plasma and components have placed a high priority on the development of new strategies for safeguarding the health of millions of patients who receive blood and tissue-derived products every year. The screening of blood for the detection of infectious agents is continuing to advance but is complicated by the presence of new and emerging pathogens. In addition, cost-effectiveness and the threat of emerging and/or crossover infective agents must also be considered. Recent advances and new strategies for the inactivation and removal of infectious agents in whole blood, cord blood, component concentrates, and plasma are the focal point of CHI's Ninth Annual Blood Product Safety conference.

Organized by:

CHI

Invited Speakers:

Dr. Kathryn Martin Remington, Bayer Corp.
Dr. Paul R. McCurdy, Consultant
Dr. Bernard Horowitz, Horowitz Consultants, LLC
Dr. Jeff Davies, ZLB Bioplasma AG (Switzerland)

Deadline for Abstracts:

Poster abstracts: January 10, 2003

Registration:

Available on-line.

E-mail:

eeskedal@healthtech.com

Posted by:

Elaine Eskedal

Host:

wks249.healthtech.com